Baseline engagement with healthy lifestyles and their associations with health outcomes in people with multiple sclerosis enrolled in an online multimodal lifestyle course
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Maggie Yu, Sandra Neate, Nupur Nag, William Bevens, George Jelinek, Steve Simpson‐Yap, Rebekah A. Davenport, Alex Fidao, Jeanette Reece |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study
par: Viviana Nociti, et autres
Publié: (2024)
par: Viviana Nociti, et autres
Publié: (2024)
Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis
par: Yi Chao Foong, et autres
Publié: (2024)
par: Yi Chao Foong, et autres
Publié: (2024)
Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta‐analysis
par: Stefano Gelibter, et autres
Publié: (2024)
par: Stefano Gelibter, et autres
Publié: (2024)
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis
par: Maria Janina Wendebourg, et autres
Publié: (2024)
par: Maria Janina Wendebourg, et autres
Publié: (2024)
Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors
par: Saira Afzal, et autres
Publié: (2024)
par: Saira Afzal, et autres
Publié: (2024)
The presence and burden of cognitive issues: discordance between the perception of neurologists and people living with multiple sclerosis
par: Iris‐Katharina Penner, et autres
Publié: (2024)
par: Iris‐Katharina Penner, et autres
Publié: (2024)
In vivo evidence for cell body loss in cortical lesions in people with multiple sclerosis
par: Eva A. Krijnen, et autres
Publié: (2024)
par: Eva A. Krijnen, et autres
Publié: (2024)
Determinants of long‐term paramagnetic rim lesion evolution in people with multiple sclerosis
par: Jack A. Reeves, et autres
Publié: (2024)
par: Jack A. Reeves, et autres
Publié: (2024)
The Australian National University Alzheimer's Disease Risk Index (ANU‐ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trial
par: Anette Hall, et autres
Publié: (2024)
par: Anette Hall, et autres
Publié: (2024)
The influence of menopause on multiple sclerosis
par: Cecilia Smith Simonsen, et autres
Publié: (2024)
par: Cecilia Smith Simonsen, et autres
Publié: (2024)
Rituximab treatment in pediatric‐onset multiple sclerosis
par: Markus Breu, et autres
Publié: (2024)
par: Markus Breu, et autres
Publié: (2024)
Pattern of paresis in amyotrophic lateral sclerosis: A cohort study
par: Nan Hu, et autres
Publié: (2024)
par: Nan Hu, et autres
Publié: (2024)
Circulating endocannabinoidome signatures of disease activity in amyotrophic lateral sclerosis
par: Raffaele Dubbioso, et autres
Publié: (2024)
par: Raffaele Dubbioso, et autres
Publié: (2024)
Loneliness as neurobehavioral issue in amyotrophic lateral sclerosis
par: Monica Consonni, et autres
Publié: (2024)
par: Monica Consonni, et autres
Publié: (2024)
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment
par: Richard Smith, et autres
Publié: (2024)
par: Richard Smith, et autres
Publié: (2024)
Association between sun exposure habits and disease progression in multiple sclerosis
par: Jing Wu, et autres
Publié: (2024)
par: Jing Wu, et autres
Publié: (2024)
Croplands proximity is associated with amyotrophic lateral sclerosis incidence and age at onset
par: Umberto Manera, et autres
Publié: (2024)
par: Umberto Manera, et autres
Publié: (2024)
Association between CD20 + T lymphocytes and neuropsychological findings in multiple sclerosis
par: Antonio Esposito, et autres
Publié: (2024)
par: Antonio Esposito, et autres
Publié: (2024)
Correction to “Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions”
Publié: (2025)
Publié: (2025)
Rethinking antisense oligonucleotide therapeutics for amyotrophic lateral sclerosis
par: Daisuke Ito, et autres
Publié: (2024)
par: Daisuke Ito, et autres
Publié: (2024)
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study
par: Susanna Hallberg, et autres
Publié: (2024)
par: Susanna Hallberg, et autres
Publié: (2024)
Elevated serum circulating cell‐free mitochondrial DNA in amyotrophic lateral sclerosis
par: Jieyu Li, et autres
Publié: (2024)
par: Jieyu Li, et autres
Publié: (2024)
Stable excess mortality in a multiple sclerosis cohort diagnosed 1970–2010
par: M.‐L. Sumelahti, et autres
Publié: (2024)
par: M.‐L. Sumelahti, et autres
Publié: (2024)
Exploring amyotrophic lateral sclerosis through the visual system: A systematic review
par: Raoul K. Khanna, et autres
Publié: (2024)
par: Raoul K. Khanna, et autres
Publié: (2024)
Three‐dimensional magnetic resonance imaging of Baló‐like concentric lesion in multiple sclerosis
par: Kazunori Iwao, et autres
Publié: (2024)
par: Kazunori Iwao, et autres
Publié: (2024)
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis
par: Jens Ingvarsson, et autres
Publié: (2024)
par: Jens Ingvarsson, et autres
Publié: (2024)
Clinical and neuroimaging characteristics of primary lateral sclerosis with overlapping features of progressive supranuclear palsy
par: Negin Badihian, et autres
Publié: (2024)
par: Negin Badihian, et autres
Publié: (2024)
Reliability study for the Japanese version of the Columbia Muscle Cramp Scale in amyotrophic lateral sclerosis
par: Masahiro Sawada, et autres
Publié: (2024)
par: Masahiro Sawada, et autres
Publié: (2024)
Vascular risk factors are associated with grey matter atrophy in secondary progressive multiple sclerosis
par: Nevin A. John, et autres
Publié: (2024)
par: Nevin A. John, et autres
Publié: (2024)
Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment
par: Francesca Trojsi, et autres
Publié: (2024)
par: Francesca Trojsi, et autres
Publié: (2024)
Fasciculations detected by muscle ultrasonography in the early stage of amyotrophic lateral sclerosis: An autopsy case
par: Hideyuki Moriyoshi, et autres
Publié: (2024)
par: Hideyuki Moriyoshi, et autres
Publié: (2024)
Early intensive therapy versus escalation strategy in French Caribbean multiple sclerosis cohort
par: Thomas David, et autres
Publié: (2025)
par: Thomas David, et autres
Publié: (2025)
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis
par: Pietro Iaffaldano, et autres
Publié: (2024)
par: Pietro Iaffaldano, et autres
Publié: (2024)
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
par: Kian Jalaleddini, et autres
Publié: (2024)
par: Kian Jalaleddini, et autres
Publié: (2024)
Rituximab in secondary progressive multiple sclerosis: a meta‐analysis
par: Pasin Intarakhao, et autres
Publié: (2024)
par: Pasin Intarakhao, et autres
Publié: (2024)
Pharmacological and non‐pharmacological treatments in amyotrophic lateral sclerosis: an Italian real‐world data study
par: Olga Paoletti, et autres
Publié: (2024)
par: Olga Paoletti, et autres
Publié: (2024)
Global functional connectivity reorganization reflects cognitive processing speed deficits and fatigue in multiple sclerosis
par: Pavel Hok, et autres
Publié: (2024)
par: Pavel Hok, et autres
Publié: (2024)
An MRI assessment of mechanisms underlying lesion growth and shrinkage in multiple sclerosis
par: Ermelinda De Meo, et autres
Publié: (2025)
par: Ermelinda De Meo, et autres
Publié: (2025)
Deep developmental phenotyping in children with tuberous sclerosis complex, with and without autism
par: Rebecca A. Mitchell, et autres
Publié: (2025)
par: Rebecca A. Mitchell, et autres
Publié: (2025)
Intrinsic and extrinsic contributors to subregional thalamic volume loss in multiple sclerosis
par: Eva A. Krijnen, et autres
Publié: (2024)
par: Eva A. Krijnen, et autres
Publié: (2024)
Documents similaires
-
Effect of autoimmune comorbidities on multiple sclerosis course: An observational multicenter study
par: Viviana Nociti, et autres
Publié: (2024) -
Longitudinal trajectories of digital upper limb biomarkers for multiple sclerosis
par: Yi Chao Foong, et autres
Publié: (2024) -
Do immune checkpoint inhibitors affect the course of multiple sclerosis? A systematic review and meta‐analysis
par: Stefano Gelibter, et autres
Publié: (2024) -
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis
par: Maria Janina Wendebourg, et autres
Publié: (2024) -
Inflammatory disease in people with multiple sclerosis treated with immune checkpoint inhibitors
par: Saira Afzal, et autres
Publié: (2024)